Search results for "Diabetes"


 
Results 51 - 60 of about 963 for "Diabetes".
Sort by: Relevance | Newest | Oldest

Antifracture effects of zoledronate persist for up to 3.5 years, study suggests

Fracture rates rose from 15 per 1,000 woman-years in the last two years of a six-year trial to 24 fractures in the first two years of follow-up. In the next two years of follow-up, the rate substantially increased to 42 fractures per 1,000 woman-years.
https://immattersacp.org/weekly/archives/2024/03/12/4.htm
12 Mar 2024

Keep a close eye on the kidneys in diabetes

Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020

Register for ACP's new one-day virtual diabetes course

Internists who attend “Diabetes for the Internist: ACP Virtual Live” will learn the latest information on caring for patients with diabetes, gain CME/MOC, and have their clinical questions answered by experts in the field.
https://immattersacp.org/weekly/archives/2021/05/18/5.htm
18 May 2021

Intensive food-as-medicine program improves engagement, not glycemic control

Patients with diabetes and food insecurity who received healthy groceries, dietitian consults, nurse evaluations, health coaching, and diabetes education had increased engagement with preventive care but no significant change in HbA1c levels versus usual care.
https://immattersacp.org/weekly/archives/2024/01/02/2.htm
2 Jan 2024

Points on providing gender-affirming care

There are simple things that physicians can do, regardless of their practice setting, to communicate to patients that they are safe in the clinical space.
https://immattersacp.org/archives/2024/02/points-on-providing-gender-affirming-care.htm
1 Feb 2024

GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes

An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021

Salt tablets no salve for hyponatremia

At Kidney Week in fall 2023, an endocrinologist covered the latest in outpatient diagnosis and treatment of syndrome of inappropriate antidiuresis (SIAD).
https://immattersacp.org/archives/2024/02/salt-tablets-no-salve-for-hyponatremia.htm
1 Feb 2024

Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes

An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://immattersacp.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023

Managing patients with diabetes and heart failure

Good control of diabetes in the presence of heart failure includes appropriate HbA1c targets, metformin and comprehensive lifestyle change as first-line therapy, and a team approach.
https://immattersacp.org/archives/2019/11/managing-patients-with-diabetes-and-heart-failure.htm
1 Nov 2019

Large review compares benefits, harms of drugs to treat type 2 diabetes

High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next